AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
News Sep 15, 2008
AnaSpec and Cyclex Co. Ltd. have announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent.
"We are pleased to partner with Cyclex in expanding our array of next generation assay kits," noted Dr. Anita Hong, AnaSpec's president.
"The new SensoLyte™ HDAC assay kits will provide our customers with new long wavelength options for the detection of histone deacetylase activity. AnaSpec also plans to develop other long wavelength HDAC related kits including SIRT assay kits."
Protein's Role in Mitochondrial Metabolism IdentifiedNews
EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.READ MORE
Proteasome Blocker Brings Glaucoma Gene Therapy CloserNews
An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.READ MORE